Data / Drug companies / Hovione Farmaciencia SA
Hovione Farmaciencia SA: 48 products in the FDA NDC directory, labeler code 50909
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Hovione Farmaciencia SA (labeler code 50909) lists 48 products in the FDA National Drug Code Directory. By type: 30 drugs for further processing, 18 bulk ingredients. Its main marketing category is drugs for further processing. The newest product started marketing on May 13, 2026.
The request: Watch Hovione Farmaciencia SA (FDA labeler code 50909): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50909
- Products in commercial distribution
- 48
- Packages
- 48
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- November 1, 1986
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 30 | 62.5% |
| Bulk ingredients | 18 | 37.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 30 | 62.5% |
| Bulk ingredients | 18 | 37.5% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 46 | 95.8% |
| Capsule | 1 | 2.1% |
| Tablet, coated | 1 | 2.1% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sonrotoclax (bgb-11417) sdd | 50909-1928 | Powder | Drugs for further processing | May 13, 2026 |
| Vepdegestrant spray dried dispersion | 50909-1927 | Powder | Drugs for further processing | May 1, 2026 |
| Paltusotine.hcl sdd | 50909-1913 | Powder | Drugs for further processing | September 25, 2025 |
| Zongertinib film-coated tablets, 60 mg | 50909-2002 | Tablet, coated | Drugs for further processing | August 16, 2025 |
| Zongertinib sdd intermediate | 50909-1914 | Powder | Drugs for further processing | August 8, 2025 |
| Dhe spray dried dispersion | 50909-1926 | Powder | Drugs for further processing | April 30, 2025 |
| Viseltinib | 50909-1707 | Powder | Bulk ingredients | February 14, 2025 |
| Suzetrigine spay dried dispersion | 50909-1910 | Powder | Drugs for further processing | January 30, 2025 |
| Deutivacaftor spray dried dispersion | 50909-1908 | Powder | Drugs for further processing | December 20, 2024 |
| Orforglipron sdd | 50909-1925 | Powder | Drugs for further processing | December 11, 2024 |
| Orforglipron sdd | 50909-1924 | Powder | Drugs for further processing | December 11, 2024 |
| Tobramycin 28mg inhalation powder hard capsule | 50909-2001 | Capsule | Drugs for further processing | November 20, 2024 |
| Ensifentrine | 50909-1705 | Powder | Bulk ingredients | June 26, 2024 |
| Alxn2040/hpmcas solid dispersion | 50909-1907 | Powder | Drugs for further processing | April 1, 2024 |
| Quizartinib dihydrochloride sdd | 50909-1915 | Powder | Drugs for further processing | July 20, 2023 |
| Pirtobrutinib sdd | 50909-1923 | Powder | Drugs for further processing | January 27, 2023 |
| Pralsetinib sdd intermediate | 50909-1905 | Powder | Drugs for further processing | December 7, 2022 |
| Solid dispersion of bms-986165-01 | 50909-1906 | Powder | Drugs for further processing | July 5, 2022 |
| Belzutifan spray dried intermediate | 50909-1917 | Powder | Drugs for further processing | August 13, 2021 |
| 26% hm30181 based solid dispersion | 50909-1904 | Powder | Drugs for further processing | March 5, 2021 |
| Tezacaftor spray dried dispersion | 50909-1903 | Powder | Drugs for further processing | February 8, 2021 |
| Ivacaftor spray dried dispersion | 50909-1902 | Powder | Drugs for further processing | February 8, 2021 |
| Tucatinib solid dispersion intermediate | 50909-1911 | Powder | Drugs for further processing | April 17, 2020 |
| Tenapanor hydrochloride | 50909-1706 | Powder | Bulk ingredients | December 9, 2019 |
| Ledipasvir sdd 50% w/w | 50909-1920 | Powder | Drugs for further processing | August 28, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.